II
Ishara Investments Portfolio holdings
AUM
$99M
This Fund
S&P 500
1 Year Est. Return
–
AUM
$99M
AUM Growth
+$13.1M
(+15%)
Holding
55
Top Buys
| 1 | +$7.08M | |
| 2 | +$4.46M | |
| 3 | +$3.53M | |
| 4 |
Arrowhead Research
ARWR
|
+$3.5M |
| 5 |
Verastem
VSTM
|
+$3.39M |
Top Sells
| 1 | +$5.4M | |
| 2 | +$3.58M | |
| 3 | +$3.24M | |
| 4 |
BridgeBio Pharma
BBIO
|
+$2.75M |
| 5 |
United Therapeutics
UTHR
|
+$2.68M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Nuvation Bio
NUVB
$1.65B
| – | – |
-400,000
|
|
||
52
Olema Pharmaceuticals
OLMA
$1.13B
| – | – |
-30,000
|
|
||
53
Syndax Pharmaceuticals
SNDX
$1.74B
| – | – |
-100,000
|
|
||
54
Tarsus Pharmaceuticals
TARS
$2.58B
| – | – |
-24,000
|
|
||
|
55
United Therapeutics
UTHR
$24.2B
| – | – |
-5,500
|
|